Prestige Consumer Healthcare
PBH
#4645
Rank
NZ$4.05 B
Marketcap
NZ$85.57
Share price
1.47%
Change (1 day)
-32.49%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2026 (TTM): NZ$6.73

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is NZ$6.79. In 2025 the company made an earnings per share (EPS) of NZ$6.57 a decrease over its 2024 EPS that were of NZ$7.41.

EPS history for Prestige Consumer Healthcare from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$6.732.54%
2025NZ$6.57-11.4%
2024NZ$7.41-367.08%
2023NZ-$2.77-138.33%
2022NZ$7.2411.7%
2021NZ$6.4813.6%
2020NZ$5.70-651.67%
2019NZ-$1.03-148.78%
2018NZ$2.12-83.29%
2017NZ$12.68437.23%
2016NZ$2.36-34.13%
2015NZ$3.5852.94%
2014NZ$2.34-8.11%
2013NZ$2.55
2011NZ$1.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.05 121.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
NZ$12.05 77.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.10 78.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.26-66.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.22-8.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
NZ$10.65 56.85%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
NZ$3.98-41.37%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.70-1.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
NZ-$51.04-851.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$2.10-69.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel